Symptom overlap for malaria and pneumonia--policy implications for home management strategies

Karin Källander1, Jesca Nsungwa-Sabiiti, Stefan Peterson

  • 1Karolinska Institutet, Division of International Health (IHCAR), Stockholm 17176, Sweden. karin.kallander@phs.ki.se

Acta Tropica
|June 5, 2004
PubMed

Insights

In Sub-Saharan Africa, many children have overlapping malaria and pneumonia symptoms. Community health strategies must address this dual diagnosis for effective treatment of childhood illness.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Malaria and pneumonia are leading causes of mortality in children under five in Sub-Saharan Africa (SSA).
  • Current Integrated Management of Childhood Illness (IMCI) protocols rely on presumptive diagnoses at health facilities.
  • Fever suggests malaria, while cough, difficult breathing, and fast breathing indicate pneumonia.

Purpose of the Study:

  • To investigate the prevalence of overlapping malaria and pneumonia symptoms in Ugandan children.
  • To highlight the need for integrated management strategies at the community level.

Main Methods:

  • Retrospective analysis of clinical data from 3671 Ugandan children under five.
  • Data collected from 14 health centers in Uganda.
  • Examination of symptom overlap between malaria and pneumonia diagnoses.

Main Results:

  • 30% of children presented with symptoms consistent with both malaria and pneumonia, requiring dual treatment.
  • Among cases presumed to be malaria, 37% also exhibited signs of pneumonia.
  • Significant symptom overlap necessitates revised treatment protocols.

Conclusions:

  • The presumptive diagnosis approach for malaria and pneumonia in SSA leads to frequent co-occurrence of symptoms.
  • Home management of malaria strategies must incorporate the dual diagnosis of malaria and pneumonia.
  • Integrated community-based management is crucial for effectively treating sick children in SSA.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...